Phase II Pilot of Aromatase Inhibitor Therapy With Femara (Letrozole) and Ovarian Suppression in Premenopausal Estrogen Receptor Positive Women With Stage IV Carcinoma of the Breast.
Phase of Trial: Phase II
Latest Information Update: 08 May 2013
At a glance
- Drugs Letrozole (Primary) ; Goserelin; Leuprorelin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 21 Mar 2012 Actual patient number is 1 according to ClinicalTrials.gov.
- 01 Oct 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.